Xcout Intel
Blue Marlin Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Blue Marlin Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Blue Marlin Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Blue Marlin Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Blue Marlin Therapeutics, Inc.
Blue Marlin Therapeutics is developing a non-viral, in vivo immune-cell engineering platform that combines targeted lipid nanoparticle delivery, genomic integration, and promoter-gated expression. The company aims to provide durable, cell-specific therapies for patients with oncology and autoimmune diseases.
Blue Marlin Therapeutics, Inc. at a glance
Blue Marlin Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $100,000 in October 2025. Xcout tracks 9 named people at Blue Marlin Therapeutics, Inc., including Sean Stalfort (President).
Blue Marlin Therapeutics, Inc. leadership
- Sean StalfortPresident
- Sean StalfortCEO & Founder
- Joseph SennChief Development and Science Officer & Co-founder
- Oleg IartchoukHead of Research & Co-founder
- Justin PowersHead of Business Development
- Edward OakeleyExecutive Director, Bioinformatics and Data Analysis
3 more named people on record for Blue Marlin Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Blue Marlin Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $100,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Blue Marlin Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Blue Marlin Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Walking Fish Therapeutics develops cell-based therapeutics by engineering B cells to act as protein factories for the treatment of serious diseases, including oncology, regenerative medicine, autoimmune diseases, and rare deficiency diseases. The company utilizes a proprietary B cell platform to deliver various therapeutic proteins such as replacement proteins, immune-inhibitory proteins, and engineered antibodies.
Biotech
Sail Biomedicines develops a new class of RNA medicines and in vivo CAR-T cell therapies designed to reset autoimmunity and treat immune-mediated diseases. The company utilizes an integrated platform combining Endless RNA (eRNA) constructs and targeted nanoparticles to deliver protein cargos directly to specific immune cells inside the body.
Biotech
Adaptin Bio is a biotechnology company developing a proprietary drug delivery platform designed to enhance the transfer of therapeutics across biological barriers into the brain and other targeted tissues. Its lead technology, the Brain Bispecific T cell Engager (BRiTE) platform, manipulates the human immune system to target diseases in oncology, central nervous system disorders, autoimmune conditions, and cardiovascular markets.
Biotech
CPTx is a genetic medicines company that develops in vivo CAR-T therapies for cancer treatment. The company utilizes a proprietary single-stranded DNA (ssDNA) platform combined with lipid nanoparticle delivery systems to create scalable, non-viral genetic therapies.
Similar biotechnology company
ImCheck Therapeutics designs and develops next-generation immunotherapeutic antibodies focused on modulating the immune system through the butyrophilin and butyrophilin-like superfamily of checkpoint molecules. The company's pipeline targets treatments for cancer, infectious disease, and autoimmune disease.
Similar biotechnology company
Base Therapeutics is a biotechnology company that develops next-generation gene editing technologies, including its proprietary AccuBase base editing system and enhanced prime editing technology. The company focuses on creating therapeutic solutions for cancer and genetic diseases, alongside engineered immune cell therapies such as BASE-NK and CAR-T products. It serves patients and partners with pharmaceutical and agricultural enterprises by licensing its precision gene editing tools.
Similar biotechnology company
BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.
Biotech
Bellicum Pharmaceuticals, Inc. is a company focused on engineering high-performance cellular immunotherapies. These therapies are developed to combat diseases.
Similar biotechnology company
Hunterian Medicine LLC is a gene-editing company that develops CRISPR-based therapeutics to cure genetic diseases. The company utilizes a patented platform technology with a bidirectional promoter to enable efficient, on-target delivery of CRISPR via a single adeno-associated virus (AAV).
Similar biotechnology company
Luminary Therapeutics, Inc. is a pre-clinical stage cell therapy development company located in Minneapolis, Minnesota, focused on creating non-viral cell therapies.
Similar biotechnology company
YolTech Therapeutics is a clinical-stage biotechnology company that specializes in developing in vivo gene editing therapies and mRNA drugs for serious diseases. The company utilizes novel CRISPR-Cas enzymes, base editors, and lipid nanoparticle delivery systems to create precision genetic medicines.
Similar biotechnology company
Pan Cancer T develops pioneering T-cell receptor (TCR-T) cell therapies designed to empower patients' immune systems to target and overcome solid tumors. The company utilizes proprietary gene engineering to enhance T-cell fitness and persistence against unique cancer-specific intracellular targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Blue Marlin Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Blue Marlin Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →